Bacterial intracellular proteins

Bacterial intracellular proteins represent a broad category of molecular targets located within the cytoplasm of bacteria, essential for survival, growth, and replication (National Center for Biotechnology Information). This group includes critical machinery such as the 30S and 50S ribosomal subunits, which are targeted by classes like tetracyclines and macrolides to inhibit protein synthesis (StatPearls). Other vital intracellular targets include enzymes involved in nucleic acid synthesis, such as DNA gyrase and topoisomerase IV, targeted by fluoroquinolones, and RNA polymerase, targeted by rifamycins (Nature Reviews Microbiology). These proteins are fundamental to the pathophysiology of bacterial infections, as their inhibition leads to bacteriostatic or bactericidal effects (PubMed). While highly effective as therapeutic targets, the diversity of these proteins across different species and the emergence of mutations lead to significant challenges in antimicrobial resistance (World Health Organization). Furthermore, the structural similarity between certain bacterial proteins and human mitochondrial components can lead to off-target toxicity. Effective drug delivery to these targets requires the molecule to penetrate both the bacterial cell wall and the inner membrane. Consequently, these proteins are central to the development of narrow and broad-spectrum antimicrobial therapies.

Other names

Cytoplasmic bacterial proteinsIntracellular bacterial enzymesBacterial cytoplasmic targets

Inhibition of essential cytoplasmic processes including translation, transcription, and DNA replication through binding to specific bacterial enzymes or ribosomal subunits.